{"id":14782,"date":"2012-04-16T11:30:00","date_gmt":"2012-04-16T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/bayer-110-milioni-di-dollari-di-penalita-sui-suoi-contraccettivi-in-usa\/"},"modified":"2012-04-16T11:30:00","modified_gmt":"2012-04-16T09:30:00","slug":"bayer-110-milioni-di-dollari-di-penalita-sui-suoi-contraccettivi-in-usa","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/bayer-110-milioni-di-dollari-di-penalita-sui-suoi-contraccettivi-in-usa\/","title":{"rendered":"Bayer: 110 million dollar penalty on its contraceptives in the US"},"content":{"rendered":"<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; mso-ansi-language: EN-US\" lang=\"EN-US\">The Allemand Bayer Pharmaceutical Group will pay 110 million dollars to make money on those 500 claims against their contraceptive pills Yasmin and Yaz. Ces demi\u00e8res seraient susceptibles d&#039;entrainer la formation de caillots sanguins pouvant provoquer des infarctus et ce risqu\u00e9 n&#039;aurait pas \u00e9t\u00e9 suffisamment soulign\u00e9. C&#039;est en tout cas l&#039;avis de la FDA qui a demand\u00e9 le 10 avril dernier \u00e0 Bayer et d&#039;autres manufacturers de pilules contraceptives de le signaler plus clairement Avec 1,58 milliard de dollars de chiffre d&#039;affaires, ces contraceptifs arrivent au deuxi\u00e8me rang dans la gamme de Bayer en termes de chiffre d&#039;affaires. Bayer pr\u00e9f\u00e8re avoid the risks and the cofits of a proc\u00e8s aux Etats-Unis.<\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 12pt; mso-ansi-language: EN-US\" lang=\"EN-US\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 10pt; mso-bidi-font-weight: bold\">Les Echos<strong> <\/strong><\/span><\/em><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Arial&quot;,&quot;sans-serif&quot;; color: black; font-size: 10pt\">16-04-2012<strong><\/p>\n<p><\/strong><\/span><\/em><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 9pt\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; mso-ansi-language: EN-US\" lang=\"EN-US\">Translation:<\/p>\n<p><\/span><\/em><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt; mso-ansi-language: EN-US\" lang=\"EN-US\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/em><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><em style=\"mso-bidi-font-style: normal\"><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; font-size: 12pt\">The German pharmaceutical group <span style=\"mso-spacerun: yes\">&nbsp;<\/span>Bayer will have to pay at least $110 million to settle about 500 claims against its Yasmin and Yaz contraceptives. The latter could favor the formation of clots that can cause heart attacks and this risk is not sufficiently highlighted. This is the opinion of the FDA which on April 10 asked Bayer and other manufacturers of contraceptive pills to report it more clearly. With 1.58 billion in sales, these contraceptives come in second place in Bayer&#039;s product range in terms of sales. Bayer prefers to avoid the risks and costs of an additional trial in the United States.<\/p>\n<p><\/span><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Le groupe pharmaceutique allemand Bayer devra verser au moins 110 millions de dollars pour faire face &agrave; quelque 500 r&eacute;clamations contre ses pilules contraceptives Yasmin et Yaz. Ces demi&egrave;res seraient susceptibles d&#8217;entrainer la formation de caillots sanguins pouvant provoquer des infarctus et ce risqu&eacute; n&#8217;aurait pas &eacute;t&eacute; suffisamment soulign&eacute;. C&#8217;est en tout cas l&#8217;avis de &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14782"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}